SCHEDULE: T. Rowe Price Discloses 7% Stake in Vicor Corp

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.0% of Vicor Corp's common stock as of June 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting its beneficial ownership of Vicor Corp common stock.
• As of June 30, 2026, T. Rowe Price Associates, Inc. beneficially owns 2,368,425 shares of Vicor Corp common stock.
• This represents 7.0% of the class of securities.
• The filing indicates sole voting power over 2,199,761 shares and sole dispositive power over 2,368,425 shares.
• There is no shared voting or dispositive power reported.
• The filing is made under Rule 13d-1(b) and T. Rowe Price Associates, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant but not overwhelming stake by a major institutional investor. The filing itself is routine for Schedule 13G.

Positives

• Significant institutional ownership by a reputable asset manager (T. Rowe Price Associates, Inc.) can be seen as a positive signal of confidence in the company's long-term prospects.
• The reported stake of 7.0% indicates a substantial investment.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment strategy rather than activist intent.

Negatives

• The filing is a routine disclosure and does not contain new operational or financial performance data, thus offering no direct insight into current company performance.
• The filing does not provide details on the specific investment strategy or the rationale behind acquiring this stake.

Risks

• While not explicitly stated as a risk in this filing, significant institutional ownership can sometimes lead to increased volatility if the institution decides to alter its position.
• The filing does not discuss any specific risks related to Vicor Corp's business operations or market conditions.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance regarding Vicor Corp's future performance.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that significant filings like this Schedule 13G from major asset managers are common in the technology and industrial sectors, reflecting active portfolio management and strategic positioning by institutional investors.

Stakeholder Impact

• Shareholders: The increased visibility of a significant institutional holder like T. Rowe Price may attract further investor interest, potentially influencing share price. However, it also means a large block of shares is managed by a single entity, which could impact liquidity if they decide to sell.
• Management: The presence of a substantial institutional investor may lead to increased scrutiny of management's performance and strategic decisions.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• T. Rowe Price Associates, Inc. will continue to hold its shares in Vicor Corp, subject to its investment policies and market conditions.
• Future amendments to this Schedule 13G will be filed if ownership levels change significantly.

Key Dates

Keywords

Vicor Corp, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Securities Ownership